Skip to main content

Table 2 Clinical characteristics of the NUP98 high and low samples within the in-house TNBC gene expression datasets

From: NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

 

Nup98 low (N = 30)

Nup98 high (N = 30)

Age

< 40

3

5

40–49

11

12

50–59

6

6

60+

10

7

T code

1

11

9

2–4

19

21

N code

0

18

21

1–3

12

9

LVI

present

14

15

Not seen

16

15